about
Immunogenicity in xenogeneic scaffold generation: antigen removal vs. decellularizationHarnessing B cells in immunotherapyTransgenic expression of HLA-E single chain trimer protects porcine endothelial cells against human natural killer cell-mediated cytotoxicityPEDE (Pig EST Data Explorer): construction of a database for ESTs derived from porcine full-length cDNA librariesRat genotype influences quantitative and qualitative aspects of xenogeneic immune response to pig blood mononuclear cells.Co-stimulation blockade targeting CD154 and CD28/B7 modulates the induced antibody response after a pig-to-baboon cardiac xenograft.Targeted toxin-based selectable drug-free enrichment of Mammalian cells with high transgene expression.Toward development and production of human T cells in swine for potential use in adoptive T cell immunotherapy.Genetic modification of xenografts.Genetic therapies and xenotransplantation.Xenotransplantation and other means of organ replacement.Current status of animal-to-human transplantation.Antibodies in transplantation.Donor specific antibodies after transplantationEngraftment of Human Glioblastoma Cells in Immunocompetent Rats through Acquired Immunosuppression.Embryonic committed stem cells as a solution to kidney donor shortage.Immune problems in central nervous system cell therapy.Organ transplantation--how much of the promise has been realized?The paradoxical functions of B cells and antibodies in transplantationNovel functions of B cells in transplantation.Noncognate function of B cells in transplantation.In vivo xenogeneic scaffold fate is determined by residual antigenicity and extracellular matrix preservation.Role of xenotransplantation in cardiac transplantation.In vitro and in vivo prevention of human CD8+ CTL-mediated xenocytotoxicity by pig c-FLIP expression in porcine endothelial cells.Exploiting virus stealth technology for xenotransplantation: reduced human T cell responses to porcine cells expressing herpes simplex virus ICP47.Xenotransplantation of human unrestricted somatic stem cells in a pig model of acute myocardial infarction.Immune cells in a heterotopic lamb-to-pig bronchial xenograft model.Human antibody reactivity against xenogeneic N-glycolylneuraminic acid and galactose-α-1,3-galactose antigen.Genomic structure around joining segments and constant regions of swine T-cell receptor alpha/delta (TRA/TRD) locus.A combination of targeted toxin technology and the piggyBac-mediated gene transfer system enables efficient isolation of stable transfectants in nonhuman mammalian cells.Xenoreactive CD4+ memory T cells resist inhibition by anti-CD44 mAb and reject islet grafts via a Th2-dependent pathway.Combination of antibodies inhibits accelerated rejection mediated by memory T cells in xenoantigen-primed mice.Blockade of indirect recognition mediated by CD4+ T cells leads to prolonged cardiac xenograft survival.Sequential hydrophile and lipophile solubilization as an efficient method for decellularization of porcine aortic valve leaflets: Structure, mechanical property and biocompatibility study.As2 O3 combined with leflunomide prolongs heart xenograft survival via suppressing the response of Th1, Th2, and B cells in a rat model.Complement dependent early immunological responses during ex vivo xenoperfusion of hCD46/HLA-E double transgenic pig forelimbs with human blood
P2860
Q26851589-6C744AD5-4AB3-4914-B45E-2E5299DAC661Q28066838-18EECCF6-72BF-4FF5-BF46-C67F5DB5C5FAQ29026229-D3482441-191D-4E6E-82CC-B731E2FEAD3BQ30886382-2F21B2DB-72E1-4920-8914-8D47700B0C84Q33246506-6ECB2AF2-A1D8-426C-89AD-5EED8875CD46Q33365683-0196EE1B-C789-40BC-8FAD-570281FDC326Q33565427-4AD6A704-5AA8-47FD-8301-8B0AE4D8F693Q33606412-49390B61-B827-42BD-A8C0-114276A4E4E4Q34311785-DEE97421-E841-4ECE-AEC8-61DF479A7947Q34560676-B4812224-3FEE-40CA-80AF-EB6907C6DDA6Q34572172-64350463-B73C-42FA-AE13-09B9234F2202Q34665240-DE557A9E-43B7-4126-BE95-B4AD066EB377Q34667057-B3D70382-616A-4D6C-84AB-7C2CF38FD993Q35388861-44FBA3A8-9BA1-432F-BAC7-0041998458A9Q35751304-2FA3BDDF-B870-414A-9BEA-70D8D3125049Q35753500-A98AC14C-A564-43BF-8D35-27380A9176B8Q36045396-E1B85F13-AF7F-4120-960D-483E39934B45Q36152685-2A2818FB-7E6B-4D1A-A7B3-375CA3D2B4E2Q36563918-12C5A45E-8211-4C51-ABE1-F46E98A551FCQ36865787-9E52DB24-480F-4CB6-B0A2-F0D5F4BC83DAQ37379253-CD3982FC-31DF-4B7D-90ED-C82871DA678EQ37621118-AF2CD2EF-E58A-46FF-A163-D74C9D7FCB72Q38262811-D289DE7C-8E4F-49A2-ACF3-53FEC66352ACQ40022094-0D090475-7419-4BE9-B349-3F94F982D995Q40676402-E40AFC9C-0FEA-4FFB-831E-3B4045CC6ED9Q43724121-94D935FB-50C9-40BD-A404-701D87045D9BQ46651481-A7FFA877-04C5-4E30-AA00-5E4F4A1B4F63Q48177022-263764E5-6961-4910-8512-AB8E32090FC4Q48236187-87A7AC32-BF61-4F3A-9477-66386061099FQ50447065-B632ED0A-506C-458F-B002-786C0296E1FEQ50996085-28BB0F33-7C2A-4462-8841-2F59A83BAD6BQ51027138-1CF834C0-2152-4F8F-84CE-B9570EB1152BQ51038145-AF92F1AF-3E22-45A6-8755-54902DD1C32EQ51081150-2077F34E-2800-4F37-911B-5565A9634124Q51328345-52C4C472-1B61-4D54-B95F-3FB679684CB9Q57197924-0E83F359-BFAB-4BB5-ABBE-0DD334250470
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The immunological barrier to xenotransplantation.
@ast
The immunological barrier to xenotransplantation.
@en
The immunological barrier to xenotransplantation.
@nl
type
label
The immunological barrier to xenotransplantation.
@ast
The immunological barrier to xenotransplantation.
@en
The immunological barrier to xenotransplantation.
@nl
prefLabel
The immunological barrier to xenotransplantation.
@ast
The immunological barrier to xenotransplantation.
@en
The immunological barrier to xenotransplantation.
@nl
P1433
P1476
The immunological barrier to xenotransplantation
@en
P2093
P304
P356
10.1016/S1074-7613(01)00124-8
P407
P577
2001-04-01T00:00:00Z